Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Zosyn® (piperacillin/tazobactam) – New warning
May 5, 2017 – The FDA approved an update to the Warnings and Precautions section of the Zosyn(piperacillin/tazobactam) drug label, regarding nephrotoxicity in critically ill patients.
